Immune Regulation by Atypical Chemokine Receptors The authors discuss the biochemical and immunological properties of atypical chemokine receptors and the potential unifying themes in this family, and they highlight recent studies that identify novel roles for these molecules in development, homeostasis, inflammatory disease, infection and cancer. [Nat Rev Immunol]Abstract

Tapimmune Announces Development of Advanced Immunotherapeutic Vaccine Expression and Delivery System TapImmune announced development of an immunotherapeutic vaccine expression and delivery system. The novel platform is termed TapImmune’s PolyStart™ technology and has been strategically designed to directly enhance the immune system’s ability to stimulate either or BOTH cytotoxic killer and helper T-cell reactive proprietary peptides, known and expected to be associated with one, or more importantly, ANY cancer, infectious disease or bio-threat. [TapImmune Inc.]Press Release

Roswell Park Cancer Institute, University of Pittsburgh Cancer Institute Awarded $11 Million SPORE Grant With more than $11 million in funding from the National Cancer Institute, Roswell Park Cancer Institute, in collaboration with the University of Pittsburgh Cancer Institute, will embark on a search for ways to prevent and cure ovarian cancer. Distributed over five years, the funds will come through a Specialized Program of Research Excellence (SPORE) grant. The research team will study novel immunotherapy approaches for the treatment of and risk assessment for ovarian cancer. [Roswell Park Cancer Institute]Press Release